Twelve-member IPANEMA consortium implements competences of participating academic and industry beneficiaries and Third Country(TC) partners to:

create a knowledge / experience – sharing network of scientists, entrepreneurs & end-users in the multidisciplinary field of biosensors for POCT (point-of-care testing)

develop innovative bottom-up approaches for fabrication of low-cost POCT devices and implementation of paper-based nucleic acid testing (NAT)

pursue applications in 3 important industry sectors: healthcare, agrifood
environmental monitoring

Research & Innovation (R&I) activities will be focused on developing low-cost paper-based isothermal NATs, their integration into microfluidic devices and optimization for use in

tissue engineering
agrifood (poultry/plant/fungal) pathogen detection
detection of toxigenic freshwater Cyanobacteria causing harmful algal blooms

Isothermal nucleic acid amplification tests (isoNATs) are increasingly used to facilitate detection of DNA or RNA associated with bacteria, viruses or other pathogens even when present in very small quantities. However, they are still relatively complex and expensive for widespread use in point-of-care (POC) rapid diagnostic systems. IPANEMA has formed a large network of multidisciplinary expertise to effectively bring into practice the potential of paper-based microfluidic biosensing platforms harnessing isoNATs.


IPANEMA consortium, comprising beneficiaries from Europe and partners from USA and P.R. China, spanning both private and academic sectors, works on several different detection technologies that can be integrated with smart phones for sophisticated yet cost-effective and

easy-to-use POC diagnostics.

Several transducing methods
(colorimetric, fluorescence, SPR,
electrochemical, microwave & magnetic)
and smartphone-based read-out methods
will be investigated for POCT use

Secondments & trainings will enable
researchers to acquire both technical &
soft skills needed for converting
knowledge & ideas into
products & services

Get the
latest news in
your inbox!


This project has received funding from
the European Union’s Horizon 2020 research and
innovation programme under the Marie Skłodowska-Curie grant agreement No 872662